Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4 Hydroxycephalexin
2. 4-hydroxycephalexin
3. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))-
4. Bidocef
5. Bl S 578
6. Bl S578
7. Bl-s 578
8. Bl-s578
9. Bls 578
10. Bls578
11. Cefadroxil Anhydrous
12. Cefadroxil Monohydrate
13. Cephadroxyl
14. Duricef
15. S 578
16. S-578
17. S578
18. Ultracef
1. 50370-12-2
2. Cefadroxil Anhydrous
3. Cephadroxil
4. Cefadroxilo
5. Cefadroxilum
6. D-cefadroxil
7. Cefadroxil [inn]
8. Bl-s578
9. Anhydrous Cefadroxil
10. Chebi:3479
11. (6r,7r)-7-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
12. (6r,7r)-7-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
13. Bl-s 578
14. Cdx
15. Q525pa8jjb
16. Duracef
17. Nsc-756664
18. Dsstox_cid_2749
19. Dsstox_rid_76714
20. Dsstox_gsid_22749
21. Mjf-11567-3
22. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
23. Cefadroxil (as Monohydrate)
24. Cefadroxilum [inn-latin]
25. Cefadroxilo [inn-spanish]
26. (6r,7r)-7-[(2r)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
27. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2r)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r,7r)-
28. Sumacef (tn)
29. Cefadroxil/cefadroxil Hemihydrate
30. S 578
31. S-578
32. Unii-q525pa8jjb
33. Cefradroxil
34. Cefadrops
35. Ncgc00016858-01
36. (6r,7r)-7-(((2r)-2-amino-2-(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
37. Einecs 256-555-6
38. Cas-50370-12-2
39. Cefadroxil, Anhydrous
40. Cefadroxil (jp17)
41. Spectrum_000104
42. Cefadroxil [mi]
43. Cefadroxil [jan]
44. (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
45. Prestwick0_000434
46. Prestwick1_000434
47. Prestwick2_000434
48. Prestwick3_000434
49. Spectrum2_000087
50. Spectrum4_000266
51. Spectrum5_000663
52. Epitope Id:117131
53. Cefadroxil [who-dd]
54. Chembl1644
55. Bspbio_000448
56. Kbiogr_000732
57. Kbioss_000544
58. (6r,7r)-7-((r)-2-amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
59. Mls002207219
60. Divk1c_000409
61. Schembl151320
62. Spbio_000014
63. Spbio_002387
64. Cefadroxil, Analytical Standard
65. Bpbio1_000494
66. Gtpl4831
67. Dtxsid8022749
68. Hms501e11
69. Kbio1_000409
70. Kbio2_000544
71. Kbio2_003112
72. Kbio2_005680
73. Ninds_000409
74. Hms1569g10
75. Hms2096g10
76. Hms3713g10
77. Pharmakon1600-01500163
78. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2r)-2-amino-2-(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r,7r)-
79. Hy-b1190
80. Zinc3830391
81. Tox21_110651
82. Bbl033696
83. Bdbm50350467
84. Mfcd00865091
85. Nsc756664
86. Stk801939
87. Akos005622555
88. Tox21_110651_1
89. Ccg-220434
90. Cs-4696
91. Db01140
92. Idi1_000409
93. Ncgc00179556-01
94. Ncgc00179556-03
95. As-11655
96. Smr001306770
97. Cefprozil Impurity B [ep Impurity]
98. Sbi-0051305.p003
99. Ab00513838
100. Cefprozil E Impurity B [ep Impurity]
101. C-2462
102. C06878
103. D00257
104. D81830
105. 592c878
106. Q2319020
107. Cefprozil Monohydrate Impurity B [ep Impurity]
108. Cefadroxil Monohydrate, Antibiotic For Culture Media Use Only
109. (7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
110. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))-
111. 7beta-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic Acid
| Molecular Weight | 363.4 g/mol |
|---|---|
| Molecular Formula | C16H17N3O5S |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 363.08889182 g/mol |
| Monoisotopic Mass | 363.08889182 g/mol |
| Topological Polar Surface Area | 158 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 629 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Cefadroxil |
| PubMed Health | Cefadroxil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefadroxil monohydrate, USP is a semisynthetic cephalosporin antibiotic intended for oral administration. It is a white to yellowish-white crystalline powder. It is soluble in water and it is acid-stable. It is chemically designated as 5-Thia-1- azab... |
| Active Ingredient | Cefadroxil/cefadroxil hemihydrate |
| Dosage Form | Tablet; Capsule; For suspension |
| Route | Oral |
| Strength | eq 250mg base/5ml; eq 500mg base; eq 125mg base/5ml; eq 500mg base/5ml; eq 1gm base |
| Market Status | Prescription |
| Company | Ranbaxy; Teva Pharms; Aurobindo; Aurobindo Pharma; Lupin; Sandoz; Hikma Pharms; Orchid Hlthcare; Hikma |
| 2 of 2 | |
|---|---|
| Drug Name | Cefadroxil |
| PubMed Health | Cefadroxil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefadroxil monohydrate, USP is a semisynthetic cephalosporin antibiotic intended for oral administration. It is a white to yellowish-white crystalline powder. It is soluble in water and it is acid-stable. It is chemically designated as 5-Thia-1- azab... |
| Active Ingredient | Cefadroxil/cefadroxil hemihydrate |
| Dosage Form | Tablet; Capsule; For suspension |
| Route | Oral |
| Strength | eq 250mg base/5ml; eq 500mg base; eq 125mg base/5ml; eq 500mg base/5ml; eq 1gm base |
| Market Status | Prescription |
| Company | Ranbaxy; Teva Pharms; Aurobindo; Aurobindo Pharma; Lupin; Sandoz; Hikma Pharms; Orchid Hlthcare; Hikma |
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
FDA Label
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01DB05
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DB - First-generation cephalosporins
J01DB05 - Cefadroxil
Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Route of Elimination
Over 90% of the drug is excreted unchanged in the urine within 24 hours. Cefadroxil was detected in the placenta and breast milk.
1.5 hours
Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Thickeners and Stabilizers
Coating Systems & Additives
Solubilizers
Direct Compression
Topical
Disintegrants & Superdisintegrants
Granulation
Controlled & Modified Release
Lubricants & Glidants
Taste Masking
Parenteral
Co-Processed Excipients
Film Formers & Plasticizers
Rheology Modifiers
Emulsifying Agents
Empty Capsules
Chewable & Orodispersible Aids
API Stability Enhancers
Coloring Agents
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
24
PharmaCompass offers a list of Cefadroxil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefadroxil manufacturer or Cefadroxil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefadroxil manufacturer or Cefadroxil supplier.
PharmaCompass also assists you with knowing the Cefadroxil API Price utilized in the formulation of products. Cefadroxil API Price is not always fixed or binding as the Cefadroxil Price is obtained through a variety of data sources. The Cefadroxil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ultracef manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ultracef, including repackagers and relabelers. The FDA regulates Ultracef manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ultracef API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ultracef manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ultracef supplier is an individual or a company that provides Ultracef active pharmaceutical ingredient (API) or Ultracef finished formulations upon request. The Ultracef suppliers may include Ultracef API manufacturers, exporters, distributors and traders.
click here to find a list of Ultracef suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ultracef DMF (Drug Master File) is a document detailing the whole manufacturing process of Ultracef active pharmaceutical ingredient (API) in detail. Different forms of Ultracef DMFs exist exist since differing nations have different regulations, such as Ultracef USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ultracef DMF submitted to regulatory agencies in the US is known as a USDMF. Ultracef USDMF includes data on Ultracef's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ultracef USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ultracef suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ultracef Drug Master File in Korea (Ultracef KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ultracef. The MFDS reviews the Ultracef KDMF as part of the drug registration process and uses the information provided in the Ultracef KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ultracef KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ultracef API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ultracef suppliers with KDMF on PharmaCompass.
A Ultracef CEP of the European Pharmacopoeia monograph is often referred to as a Ultracef Certificate of Suitability (COS). The purpose of a Ultracef CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ultracef EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ultracef to their clients by showing that a Ultracef CEP has been issued for it. The manufacturer submits a Ultracef CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ultracef CEP holder for the record. Additionally, the data presented in the Ultracef CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ultracef DMF.
A Ultracef CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ultracef CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ultracef suppliers with CEP (COS) on PharmaCompass.
A Ultracef written confirmation (Ultracef WC) is an official document issued by a regulatory agency to a Ultracef manufacturer, verifying that the manufacturing facility of a Ultracef active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ultracef APIs or Ultracef finished pharmaceutical products to another nation, regulatory agencies frequently require a Ultracef WC (written confirmation) as part of the regulatory process.
click here to find a list of Ultracef suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ultracef as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ultracef API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ultracef as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ultracef and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ultracef NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ultracef suppliers with NDC on PharmaCompass.
Ultracef Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ultracef GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ultracef GMP manufacturer or Ultracef GMP API supplier for your needs.
A Ultracef CoA (Certificate of Analysis) is a formal document that attests to Ultracef's compliance with Ultracef specifications and serves as a tool for batch-level quality control.
Ultracef CoA mostly includes findings from lab analyses of a specific batch. For each Ultracef CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ultracef may be tested according to a variety of international standards, such as European Pharmacopoeia (Ultracef EP), Ultracef JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ultracef USP).
